Showing results (1-10 of 427) with videos related to
Sort By:
Pageof 43
Ebiomedicine|March 13, 2022
Mesenchymal stem cell treatment for COVID-19Ruonan Xu, Zhiqian Feng, Fu-Sheng WangCellular & Molecular Immunology|November 7, 2020
Neutrophils in liver diseases: pathogenesis and therapeutic targetsKai Liu, Fu-Sheng Wang, Ruonan XuCellular & Molecular Immunology|December 14, 2011
Liver fibrosis: mechanisms of immune-mediated liver injuryRuonan Xu, Zheng Zhang, Fu-Sheng WangCellular & Molecular Immunology|March 18, 2014
The role of neutrophils in the development of liver diseasesRuonan Xu, Huihuang Huang, Zheng Zhang, et al.Hepatology International|June 3, 2024
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis BZhiqian Feng, Junliang Fu, Lili Tang, et al.Cellular & Molecular Immunology|January 5, 2011
Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseasesHu Lin, Ruonan Xu, Zheng Zhang, et al.Stem Cell Research & Therapy|September 30, 2025
Efficacy and safety of mesenchymal stem/stromal cells and their derived extracellular vesicles for acute respiratory distress syndrome: a systematic review and meta-analysisYaxin Wu, Ruonan Xu, Yuanyuan Li, et al.Signal Transduction and Targeted Therapy|September 9, 2021
Mesenchymal stem cell therapy for severe COVID-19Lei Shi, Lifeng Wang, Ruonan Xu, et al.Immunology|November 2, 2012
Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis BRuonan Xu, Fang Lin, Jin He, et al.Cellular & Molecular Immunology|March 3, 2015
Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsisRuonan Xu, Fang Lin, Chunmei Bao, et al.Pageof 43